{"entity":{"id":"nct07529808","kind":"trial","name":"Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma","aka":[],"tldr":"A phase 1/2 trial of BHB810 in gastric & gastro-oesophageal junction cancer, oesophageal cancer, colorectal cancer and pancreatic ductal adenocarcinoma, run by BigHat Biosciences, Inc., now recruiting.","summary":"Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma is a phase 1/2 interventional study registered as NCT07529808 by BigHat Biosciences, Inc., with 164 participants planned, started 2026-07 and due to reach its primary completion in 2028-12. Interventions recorded: BHB810.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07529808","url":"https://clinicaltrials.gov/study/NCT07529808"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["gastric","esophageal","colorectal","pancreatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["bighat-biosciences"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07529808","phase":"1/2","setting":"Phase 1/2, Open-Label, Multicenter, Dose Escalation and Expansion Study of BHB810 in Participants With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma","sponsor":"BigHat Biosciences, Inc.","enrolled":164,"outcomes":[]},"route":"/trials/nct07529808/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"gastric","kind":"cancer","name":"Gastric & gastro-oesophageal junction cancer","route":"/cancers/gastric/"},{"id":"esophageal","kind":"cancer","name":"Oesophageal cancer","route":"/cancers/esophageal/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"company":[{"id":"bighat-biosciences","kind":"company","name":"BigHat Biosciences","route":"/companies/bighat-biosciences/"}]}}